Your browser doesn't support javascript.
loading
An acute flaccid paralysis surveillance-based serosurvey of poliovirus antibodies in Western Uttar Pradesh, India.
Bahl, Sunil; Gary, Howard E; Jafari, Hamid; Sarkar, Bidyut K; Pathyarch, Surendra K; Sethi, Raman; Deshpande, Jagadish.
Afiliación
  • Bahl S; National Polio Surveillance Project, WHO Country Office for India, New Delhi.
  • Gary HE; Centers for Disease Control and Prevention, Center for Global Health, Global Immunization Division, Atlanta, Georgia.
  • Jafari H; World Health Organization, Geneva, Switzerland.
  • Sarkar BK; Department of Epidemiology and Public Health, University College London, United Kingdom.
  • Pathyarch SK; National Polio Surveillance Project, WHO Country Office for India, New Delhi.
  • Sethi R; National Polio Surveillance Project, WHO Country Office for India, New Delhi.
  • Deshpande J; Enterovirus Research Center, Mumbai, India.
J Infect Dis ; 210 Suppl 1: S234-42, 2014 Nov 01.
Article en En | MEDLINE | ID: mdl-25316841
ABSTRACT

BACKGROUND:

Despite intensified use of monovalent oral poliovirus type 1 vaccine and improved coverage of immunization campaigns, wild poliovirus type 1 persisted in Indian states of Uttar Pradesh and Bihar during 2006 to 2009.

METHODS:

A serosurvey was conducted among cases of acute flaccid paralysis in the 25 high-polio-incidence districts of western Uttar Pradesh. Children were recruited by age group (6-11 months, 12-24 months, and 25-69 months) from among cases reported through the acute flaccid paralysis surveillance system between November 2008 and August 2009.

RESULTS:

Seroprevalence for type 1 wild poliovirus was >96.4% for each age group. The seroprevalence of wild poliovirus types 2 and 3 increased with age, from 36.7% to 73.4% for type 2 and from 39.0% to 74.1% for type 3. In addition to the number of type-specific vaccine doses, father's level of education, being from a Muslim family, height for age, and female sex were the socioeconomic risk factors associated with seronegativity to poliovirus.

CONCLUSIONS:

The seroprevalence and risk factors identified in this study were consistent with the epidemiology of polio, and the findings were instrumental in optimizing vaccination strategy in western Uttar Pradesh with respect to the choice of OPV types, the frequency of supplementary immunization campaigns, and the urgency to improve routine immunization services.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Parálisis / Poliovirus / Monitoreo Epidemiológico / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Asia Idioma: En Revista: J Infect Dis Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Parálisis / Poliovirus / Monitoreo Epidemiológico / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Asia Idioma: En Revista: J Infect Dis Año: 2014 Tipo del documento: Article